{{header
 | author     = 
 | related_author = United States Congress
 | translator = 
 | section    = 
 | previous   = 
 | next       = 
 | year       = 2014
 | month      = 05
 | day        = 14
 | notes      = ''{{USBill|113|S.|2338}}'' as introduced
 | categories =
 | portal     =
 | congress   = 113
 | session    = 2
 | title      = United States Anti-Doping Agency Reauthorization Act ( S. 2338; 113th Congress)
 | bill       = 2338
 | billtype   = s
 | purpose    = To reauthorize the United States Anti-Doping Agency, and for other purposes.
 | wikipedia  =
}}
      
{{Center|113th CONGRESS}}

 
{{Center|2d Session}}

 
{{Center|S. 2338}}

 
{{Center|IN THE SENATE OF THE UNITED STATES}}

  
{{Center|May 14, 2014}}

 
{{Center| 
[[w:|Mr. Rockefeller]](for himself and
[[w:|Mr. Thune]]) introduced the following bill; which was read twice and referred to the [[w:United States Senate Committee on Commerce, Science and Transportation|Committee on Commerce, Science, and Transportation]] }}

  
{{Center|A BILL}}

 To reauthorize the United States Anti-Doping Agency, and for other purposes.   

=Section 1. Short title=

This Act may be cited as the“   United States Anti-Doping Agency Reauthorization Act   ”. 

=Sec. 2. Prohibit performance-enhancing methods=

   Section 701 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 ( [http://www.law.cornell.edu/uscode/text/21/2001 21 U.S.C. 2001] )is amended—
:(1) in subsection (a) , by striking paragraph (4) ; and
:(2) in subsection (b) —
::(A) in paragraph (1) , by inserting“and be recognized worldwide as the independent national anti-doping organization for the United States”after“Committee”;
::(B) in paragraph (2) , by striking“, or performance-enhancing genetic modifications accomplished through gene-doping”and inserting“or prohibited performance-enhancing methods adopted by the Agency”;
::(C) in paragraph (3) , by striking“, or performance-enhancing genetic modifications accomplished through gene-doping”and inserting“or prohibited performance-enhancing methods adopted by the Agency”;
::(D) in paragraph (4) , by striking“and the prevention of use of performance-enhancing drugs, or performance-enhancing genetic modifications accomplished through gene-doping by United States amateur athletes; and”and inserting“, and the prevention of use by United States amateur athletes of performance-enhancing drugs or prohibited performance-enhancing methods adopted by the Agency.”; and
::(E) by striking paragraph (5) . 

=Sec. 3. Authorization of appropriations=

   Section 703 of title VII of the Office of National Drug Control Policy Reauthorization Act of 2006 ( [http://www.law.cornell.edu/uscode/text/21/2003 21 U.S.C. 2003] )is amended to read as follows:

<blockquote> 

=Sec. 703. Authorization of appropriations=

There are authorized to be appropriated to the United States Anti-Doping Agency— 
:(1)   for fiscal year 2014, $11,300,000;  
:(2)   for fiscal year 2015, $11,700,000;  
:(3)   for fiscal year 2016, $12,300,000;  
:(4)   for fiscal year 2017, $12,900,000;  
:(5)   for fiscal year 2018, $13,500,000;  
:(6)   for fiscal year 2019, $14,100,000; and  
:(7)   for fiscal year 2020, $14,800,000.  . 
</blockquote>
  
{{PD-USGov}}
[[Category:Proposed United States federal law]]
[[Category:Proposed United States federal law of the 113th Congress]]
